While the majority of COPD patients have EFL, care teams have never had a COPD NIV ventilation therapy that dynamically and automatically targets EFL. BiPAP A40 EFL is the first and only NIV therapy precision-crafted to abolish EFL in hypercapnic COPD patients. It screens, detects and auto-optimizes pressure – to treat comfortably and redefine what is possible in managing COPD.
Pressure (min to max) |
|
---|---|
BiPAP A40 EFL Modes |
|
Ventilation Features |
|
Trigger Type |
|
Breath Rate |
|
Inspiratory Time |
|
Low Flow O2 |
|
Settable Alarms |
|
Humidification |
|
Dimensions |
|
Weight |
|
---|---|
AC Voltage Source |
|
DC Power Source |
|
Sound |
|
For a complete list of specifications |
|
Pressure (min to max) |
|
---|---|
BiPAP A40 EFL Modes |
|
Weight |
|
---|---|
AC Voltage Source |
|
Pressure (min to max) |
|
---|---|
BiPAP A40 EFL Modes |
|
Ventilation Features |
|
Trigger Type |
|
Breath Rate |
|
Inspiratory Time |
|
Low Flow O2 |
|
Settable Alarms |
|
Humidification |
|
Dimensions |
|
Weight |
|
---|---|
AC Voltage Source |
|
DC Power Source |
|
Sound |
|
For a complete list of specifications |
|
You are about to visit a Philips global content page
ContinueYou are about to visit the Philips USA website.
Ik begrijp het